Martyna Maria Knopek

Martyna Maria Knopek

Auto-generated profile, based on publicly available information

Martyna Maria Knopek

Cardiology Department, Jan Karol Łukowicz Regional Specialist Hospital, Leśna 10, 89-600 Chojnice, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MKMartyna Maria Knopek
Martyna Maria Knopek
PPPaulina Prudzic
Paulina Prudzic
MLMaciej Lazarek
Maciej Lazarek
KPKamila Prusinowska Prusinowska
Kamila Prusinowska Prusinowska
ASAleksasndra Sipowicz-Woźniak
Aleksasndra Sipowicz-Woźniak
EFEwelina Flegiel
Ewelina Flegiel
In recent years both in Poland and Europe there have been observed progressive demographic changes and aging of the population. Polypharmacy can be defined as the simultaneous and regular use of at least five different drugs and is particularly often used in elderly patients due to the multimorbidity. According to some sources, elderly people take between two and nine different medications daily, of which even about 60% are inappropriate. The aim of this paper is to summarize information on polypharmacy in seniors in order to plan it as best as possible and at the same time to avoid potential adverse effects, with particular emphasis on the nervous system. One of the most significant for polypharmacy is the age structure of the society. Poland is one of the European countries where the fastest growth of this ratio is observed. Huge problem seems to be the system of educating doctors, which is not adjusted to the changing demographics of the society. Furthermore, one of the factors contributing to polypharmacy is the excessive consumption of dietary supplements by Poles, especially geriatric patients - almost half of Poles consume them regularly. Polypharmacy can be defined as the simultaneous use of at least five different drugs. It is particularly often used in elderly patients due to the multimorbidity and lack of healthcare access. The advantage of polypharmacotherapy is faster achievement of target values, which may improve the patient-doctor relationship, while the disadvantage is the increased risk of side effects. Polypharmacy is a significant problem in the European elderly, to avoid its negative effects, drugs with high bioavailability, short half-lives and a broad therapeutic spectrum are the best choice.